Charan J. Sandhu

Biography

Charan J. Sandhu

Charan Sandhu is a partner in Weil’s Technology & IP Transactions practice and is based in New York. Ms. Sandhu concentrates on the areas of complex technology transactions and intellectual property. She represents clients in matters relating to technology transfer, and the development, acquisition, use and commercial exploitation of technology and intellectual property. She has extensive experience in a wide variety of complex technology transactions, including technology development and licensing agreements, joint ventures, strategic alliances, professional services agreements, outsourcing arrangements, distribution agreements, and settlements of IP litigation.

Ms. Sandhu is consistently recognized by Chambers USA as a leading lawyer for Technology & Outsourcing, where clients praise her for her "practical and extremely knowledgeable" approach to IP and technology transactions and for “consistently producing work of the highest order.” She is also recognized by Legal 500 USIAM Licensing 250’s “World’s Leading Patent & Technology Licensing Lawyers;” and IAM Patent 1000, where she is noted as an “amazing lawyer and an outstanding drafter. She is great at building relationships with counterparties.” She is recognized as an “IP Star” for IP Transactions and Patent Strategy & Counseling by Managing Intellectual Property and as a Financial & Transactional Life Science Star by LMG Life Sciences Guide. Ms. Sandhu was named Minority Female Lawyer of the Year at the Chambers USA 2018 Women in Law Awards; named among the 2015 “Top Women” for Intellectual Property in New York by Super Lawyers; and shortlisted in the “Best in Technology” category at the Americas Euromoney Women in Business Law Awards 2016.

Ms. Sandhu is a member of the Firm’s Diversity Committee. She is also actively involved with the Firm’s pro bono efforts and regularly represents Kids in Need of Defense. Ms. Sandhu was inducted into the YWCA’s Academy of Women Leaders for her outstanding professional achievement, civic commitment and leadership. She was also featured in Profiles in Diversity Journal’s 11th Annual WomenWorthWatching® issue.

Representative Experience

  • Transaction Committee of the Board of Directors of Reynolds American Inc. in Reynolds’ $60.6 billion sale to British American Tobacco p.l.c. (BAT) of the 57.8% of Reynolds stock that BAT did not already own.
  • IMS Health Holdings, Inc. in its $17.6 billion all-stock merger of equals with Quintiles Transnational Holdings Inc.
  • Scripps Networks Interactive, Inc. in its $14.6 billion merger with Discovery Communications, Inc.
  • Nortek, Inc. in its $2.8 billion merger with Melrose Industries PLC.
  • QLT Inc. (n/k/a Novelion Therapeutics Inc.) in its acquisition of Aegerion Pharmaceuticals, Inc. and in its minority investment in Aralez Pharmaceuticals Plc.
  • Willis Group Holdings plc in its $18 billion merger of equals with Towers Watson & Co.
  • IHS Inc. in its $13 billion merger of equals with Markit Limited.
  • General Electric Capital Corporation:
    • in its $32 billion sale of its global Commercial Distribution Finance, North American Vendor Finance and North American Corporate Finance platforms to Wells Fargo & Co.
    • in its $6.9 billion sale of its United States, Mexico, Australia and New Zealand fleet businesses to Element Financial Corporation, and in the sale of its European fleet businesses to Arval Service Lease S.A.
  • General Electric Company:
    • in its $3.4 billion sale of GE Water to SUEZ.
    • in its $2.6 billion sale of GE Industrial Solutions to ABB.
    • in the development of policies, procedures and template license and development agreements for GE’s Global Research Center.
    • in the creation of a clean technology partnership and financial joint venture with the Government of Abu Dhabi. The partnership encompassed a broad range of cutting-edge clean and renewable energy initiatives, including development of R&D capacity in Abu Dhabi and collaboration on Abu Dhabi's world-leading alternative energy project in Masdar City, a carbon neutral, zero-waste city currently under development.
    • on-going representation in connection with a proposed technology joint venture with Aviation Industry Corporation of China to develop and market integrated avionics systems for commercial aircraft customers, including multiple inter-related technology transfer, license and other IP agreements.
  • Goldman Sachs Merchant Banking Division in its acquisition of Restaurant Technologies, Inc.
  • Ministry Brands, LLC:
    • in a significant investment by Insight Venture Partners with Providence exiting and Genstar retaining a significant minority position.
    • in its acquisitions of Abila, Inc., Aptify Corporation and the Faith Division of The ACTIVE Network Inc., including Fellowship One.
  • Brookfield Asset Management Inc. and Brookfield Property Partners L.P. (BPY) in BPY's $14.4 billion acquisition of the approximately 66% of common stock that it did not already own of GGP Inc. (f/k/a General Growth Properties Inc.).
  • Brookfield Asset Management in its $2.8 billion acquisition of all of the outstanding common shares not already owned by Brookfield Property Partners L.P. of Rouse Properties, Inc.
  • Acquiring Consortium led by Ray Ruiping Zhang, and also including Baring Private Equity Asia, The Crawford Group and Dongfeng Asset Management, in the Consortium's pending $938 million take-private of eHi.
  • Elizabeth Arden, Inc. in its $870 million sale to Revlon, Inc.
  • Aurora Resurgence Management Partners and Equity Group Investments in the sale of SIRVA, Inc.
  • Microsoft on a variety of IT and intellectual property transactions.
  • Sanofi in connection with potential acquisitions.
  • Exelixis in connection with on-going various drug development collaborations.
  • Lantheus Medical Imaging in connection with on-going various supply, manufacturing, licenses and marketing agreements, including negotiations with Covidien, Cardinal Health, and a subsidiary of Boehringer Ingelheim.
  • PDL Biopharma in connection with its $25 million patent litigation settlement agreement and license agreement with Alexion Pharmaceuticals regarding PDL’s patents related to the humanization of antibodies and Alexion’s humanized antibody, Soliris (eculizumab).
  • Primoris Services Corporation in its acquisition of Willbros Group, Inc.
  • Ontario Teachers' Pension Plan Board in the sale of a substantial minority stake in Flexera Software LLC
  • Technology Crossover Ventures, as lead investor, in a $550 million preferred stock financing round for Peloton Interactive Inc.
  • Universal Hospital Services, Inc. (a portfolio company of Irving Place Capital) in its combination with Federal Street Acquisition Corp., a SPAC sponsored by Thomas H. Lee Partners, in a new holding company named Agiliti, Inc. having an initial enterprise value of approximately $1.74 billion.
  • Applied Biosystems in various settlement, licensing and transactional matters.
  • Arrow International Limited and certain of its affiliates in a transaction to collaborate with King Pharmaceuticals to commercialize novel formulations of Altace (ramipril).
  • GE Healthcare in connection with GE Healthcare’s joint development agreement with the NFL to jump start the development of imaging technology that would detect concussions and encourage the creation of materials to better protect the brain from traumatic brain injury (TBI). As part of the program, GE hopes to develop machines that will predict who might sustain a concussion and show the degree of injury and the rate of recovery in real-time. The initiative also includes an open innovation challenge in which inventors, entrepreneurs, scientists, and academics will submit ideas on how to diagnose TBI and how to improve safety equipment to reduce head injuries.
  • General Electric Company and GE Healthcare on the sale of a majority stake in its Homeland Protection business to The Safran Group for $580 million.
  • Estée Lauder in a joint venture with Allergen for the development and distribution of a line of product marketed through dermatologists, plastic surgeons and other doctors
  • Warner Chilcott in the analysis of development and co-promotion agreements.
  • MedPointe Pharmaceuticals in various licensing and transactional matters.
  • CBS Corp. in the $1.8 billion acquisition of CNET Networks, Inc.
  • Yildiz Holding AS in the $850 million acquisition of Godiva Chocolatier Inc. from Campbell Soup Company.
  • Avista Capital Partners in the $525 million acquisition of Bristol-Myers Squibb Medical Imaging division from Bristol-Myers Squibb Company.
  • Bertelsmann AG (Case No. 06-15886 (9th Cir. 2006); Case No. 06-72515 (9th Cir. 2006); MDL 1369 (MHP) (N.D. Cal. 2003) in litigation over the former Napster service; successful settlements in the single largest copyright infringement case in U.S. history.
  • CBS Corporation in the division of Viacom Inc. into "New Viacom" and CBS Corporation.
  • Arca Continental, S. A. B. de C.V. in its acquisition, via a $2.7 billion joint venture with Coca-Cola Refreshments USA, Inc., of bottling operations in Texas and parts of Oklahoma, New Mexico and Arkansas.

Awards and Recognition, Speaking Engagements, Guides and Resources, Latest Thinking, Firm News & Announcements

Awards and Recognition

View all

Speaking Engagements

View all

Latest Thinking

View all

Firm News & Announcements

View all